Searched for
SIMVASTATIN
Micro Labs recalls 54,096 bottles of cholesterol drug in USMicro Labs is voluntarily recalling 54,096 bottles of Simvastatin Tablets, a drug for lowering cholesterol, in the US market for failing to...19 Mar, 2015, 06.17 PM IST- New US norms on statins to help Indian drug firmsCholesterol-reducing drugs worth nearly $15 billion (Rs 92,000 crore) were sold in the US in the year to September 2013, Bakhru wrote in hi...01 Jan, 2014, 04.06 AM IST
- FDA restricts anti-cholestrol drug heavy dosageThe US drug regulator has put restrictions on use of high dose of anti-cholesterol drug simvastatin with insignificant impact on Indian rev...10 Jun, 2011, 06.02 PM IST
- Ranbaxy to recall 3 batches of Pravastatin from UK marketRanbaxy Laboratories is recalling three batches of anticholesterol drug Pravastatin tablets from the UK market for failing to update approv...18 Dec, 2010, 04.29 AM IST
- Citigroup assigns 'sell' on BioconForeign brokerage Citigroup has assigned a ‘sell’ rating on integrated biotechnology company Biocon citing higher vulnerability of the comp...19 Aug, 2009, 02.27 AM IST
- Ranbaxy hopeful of an early resolution to USFDA banRanbaxy said that it expects an early resolution to the issue of US Food and Drug Administration banning import of 30 generic drugs manufac...17 Nov, 2008, 08.44 PM IST
- Flamingo expands CRAM pact with Israel co TevaMumbai-based Flamingo Pharmaceuticals has expanded its CRAM (contract research and manufacturing) agreement with Israel’s Teva Pharmaceutic...02 Nov, 2007, 12.45 AM IST
- Ranbaxy's Simvastatin to go Down Under by AugRanbaxy Laboratories is planning to launch cardiovascular drug Simvastatin in Australia this year.21 Jul, 2007, 03.07 AM IST
- Flamingo enters into a pact with TevaFlamingo Pharma said it has got into an agreement with Israel's generic drug maker Teva to manufacture its Zolpidem tartrate tablets, used ...19 Jul, 2007, 06.45 PM IST
- Ranbaxy gains double on high US salesRanbaxy Laboratories’ net profit doubled to Rs 520 crore in December 2006, spurred by US sales of its copy of Merck & Co’s cholesterol-lowe...19 Jan, 2007, 12.54 AM IST
- Aurobindo gets Dutch board nod for SimvastatinAurobindo Pharma has received the marketing authorisation approval for a lipid-lowering agent, Simvastatin, from Medicines Evaluation Board...11 Dec, 2006, 06.00 PM IST
- Ranbaxy wins 180-day exclusivity for simvastatinThe US Court of Appeals has upheld the 180-day exclusivity of Ranbaxy’s cholesterol-lowering drug simvastatin, reports Our Bureau. It has a...16 Nov, 2006, 12.16 AM IST
- Win some, lose someRanbaxy Laboratories’ third quarter net profit surged nearly seven times, but its share price declined after the results were announced.26 Oct, 2006, 12.25 AM IST
- New drug dose helps local firms regain health in USDomestic pharma majors are witnessing sharp recovery in their US business.21 Aug, 2006, 12.56 AM IST
- Ranbaxy, Dr Reddy's get generic shotDrug majors Dr Reddy’s Laboratories (DRL) and Ranbaxy have scored a victory for their US businesses.25 Jun, 2006, 12.00 AM IST
- Generic version of Merck's Proscar tabs from Dr. Reddy'sPharma major Dr Reddy's Laboratories announced on Saturday that it has launched the authorized generic version of Merck's Proscar tablets 5...24 Jun, 2006, 03.54 PM IST
- Ranbaxy gets USFDA nod for SimvastatinPharma major Ranbaxy Laboratories Ltd has received approval from the USFDA for manufacturing and marketing cholesterol-lowering Simvastatin...24 Jun, 2006, 12.30 PM IST
Load More
